Characterizing the practice of oocyte donation: A web-based international survey

Reproductive BioMedicine Online

Volumn 28, Issue 4, 2014, Pages 443-450

  Weissman, Ariel ^a   Leong, Milton ^b   Sauer, Mark V ^c   Shoham, Zeev ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^c Department of Obstetrics and Gynecology Columbia University College of Physicians and Surge ^*  (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

endometrial preparation; endometrium; oestrogen; oocyte donation; progesterone

Indexed keywords

ESTROGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PROGESTERONE; GONADORELIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL PRACTICE; CONSENSUS; DONOR SELECTION; ENDOMETRIAL THICKNESS; EVIDENCE BASED MEDICINE; FEMALE; FERTILIZATION IN VITRO; GENETIC SCREENING; HUMAN; INTERNET; MAJOR CLINICAL STUDY; OOCYTE DONATION; OVULATION; PHYSICIAN; AGONISTS; ANATOMY AND HISTOLOGY; ENDOMETRIUM; OVULATION INDUCTION; PREGNANCY; PROCEDURES; QUESTIONNAIRE; STANDARDS;

ADULT; ENDOMETRIUM; FEMALE; GENETIC TESTING; GONADOTROPIN-RELEASING HORMONE; HUMANS; OOCYTE DONATION; OVULATION INDUCTION; PREGNANCY; PROGESTERONE; QUESTIONNAIRES;

EID: 84897573331     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2013.12.004     Document Type: Article

References (41)

1. H.G. Al-Inany, M.A. Youssef, M. Aboulghar, F. Broekmans, M. Sterrenburg, J. Smit, and A.M. Abou-Setta Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Cochrane Database Syst. Rev. 2011 CD001750
2. ASRM and SART Practice Committee Recommendations for gamete and embryo donation: a committee opinion Fertil. Steril. 99 2013 47 62
3. J.P. Balmaceda, L. Bernardini, I. Ciuffardi, C. Felix, T. Ord, C.E. Sueldo, and R.H. Asch Oocyte donation in humans: a model to study the effect of age on embryo implantation rate Hum. Reprod. 9 1994 2160 2163
4. M.A. Barker, L.M. Boehnlein, P. Kovacs, and S.R. Lindheim Follicular and luteal phase endometrial thickness and echogenic pattern and pregnancy outcome in oocyte donation cycles J. Assist. Reprod. Genet. 26 2009 243 249
5. B.M. Berger, and J.A. Phillips Pregnancy outcomes in oocyte donation recipients: vaginal gel versus intramuscular injection progesterone replacement J. Assist. Reprod. Genet. 29 2012 237 242
6. D. Bodri, S.K. Sunkara, and A. Coomarasamy Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis Fertil. Steril. 95 2011 164 169
7. C.M. Boomsma, S.D. Keay, and N.S. Macklon Peri-implantation glucocorticoid administration for assisted reproductive technology cycles Cochrane Database Syst. Rev. 2007 CD005996
8. CDC, 2013. Assisted Reproductive Technology (ART) 2010 report. Section 4: ART Cycles Using Donor Eggs. Available from: < http://www.cdc.gov/art/ ART2010/section4.htm >.
9. E. Cicinelli, and D. de Ziegler Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus Hum. Reprod. Update 5 1999 365 372
10. A. Cobo, M. Meseguer, J. Remohi, and A. Pellicer Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial Hum. Reprod. 25 2010 2239 2246
11. M.A. Cohen, S.R. Lindheim, and M.V. Sauer Donor age is paramount to success in oocyte donation Hum. Reprod. 14 1999 2755 2758
12. P. Devroey, M. Camus, G. Palermo, J. Smitz, L. van Waesberghe, A. Wisanto, I. Wijbo, and A.C. van Steirteghem Placental production of estradiol and progesterone after oocyte donation in patients with primary ovarian failure Am. J. Obstet. Gynecol. 162 1990 66 70
13. ESHRE, 2013. Legal Documentation. Available from: < http://www.eshre.eu/ESHRE/English/Guidelines-Legal/Legal-documentation/page. aspx/145 >.
14. A.P. Ferraretti, V. Goossens, J. de Mouzon, S. Bhattacharya, J.A. Castilla, V. Korsak, M. Kupka, K.G. Nygren, and A. Nyboe Andersen Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE Hum. Reprod. 27 2012 2571 2584
15. J.A. Garcia-Velasco, V. Isaza, C. Caligara, A. Pellicer, J. Remohi, and C. Simon Factors that determine discordant outcome from shared oocytes Fertil. Steril. 80 2003 54 60
16. T.A. Gelbaya, M. Kyrgiou, T.C. Li, C. Stern, and L.G. Nardo Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis Hum. Reprod. Update 13 2007 357 364
17. D. Glujovsky, R. Pesce, G. Fiszbajn, C. Sueldo, R.J. Hart, and A. Ciapponi Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes Cochrane Database Syst. Rev. 2010 CD006359
18. M. Goudakou, A. Kalogeraki, I. Matalliotakis, Y. Panagiotidis, G. Gullo, and Y. Prapas Cryptic sperm defects may be the cause for total fertilization failure in oocyte donor cycles Reprod. Biomed. Online 24 2012 148 152
19. E. Groeneveld, K.A. Broeze, M.J. Lambers, M. Haapsamo, K. Dirckx, B.C. Schoot, B. Salle, C.I. Duvan, R. Schats, B.W. Mol, and P.G. Hompes Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA) Hum. Reprod. Update 17 2011 501 509
20. HFEA, 2009. Human Fertilisation and Embryology Authority: Donor Recruitment, Assessment and Screening. Available from: < http://www.hfea.gov. uk/498.html?fldSearchFor=egg%20donor%20screeining >.
21. IVF-Worldwide, 2012. Available from: < http://www.ivf-worldwide.com/ survey/oocyte-donation/results-oocyte-donation.html >.
22. J.S. Krasnow, B.A. Lessey, G. Naus, L.L. Hall, D.S. Guzick, and S.L. Berga Comparison of transdermal versus oral estradiol on endometrial receptivity Fertil. Steril. 65 1996 332 336
23. J. Leeton, and P. Rogers Preparation of the endometrium for egg donation J. Assist. Reprod. Genet. 10 1993 459 461
24. T.C. Li, I.D. Cooke, M.A. Warren, M. Goolamallee, R.A. Graham, and J.D. Aplin Endometrial responses in artificial cycles: a prospective study comparing four different oestrogen dosages Br. J. Obstet. Gynaecol. 99 1992 751 756
25. D.R. Meldrum, A. Wisot, F. Hamilton, A.L. Gutlay-Yeo, B. Marr, and D. Huynh Artificial agonadism and hormone replacement for oocyte donation Fertil. Steril. 52 1989 509 511
26. R.A. Miles, R.J. Paulson, R.A. Lobo, M.F. Press, L. Dahmoush, and M.V. Sauer Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study Fertil. Steril. 62 1994 485 490
27. N. Noyes, B.S. Hampton, A. Berkeley, F. Licciardi, J. Grifo, and L. Krey Factors useful in predicting the success of oocyte donation: a 3-year retrospective analysis Fertil. Steril. 76 2001 92 97
28. R.J. Paulson Hormonal induction of endometrial receptivity Fertil. Steril. 96 2011 530 535
29. J. Remohi, A. Vidal, and A. Pellicer Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization Fertil. Steril. 59 1993 1208 1215
30. J. Remohi, A. Gutierrez, A. Vidal, J.J. Tarin, and A. Pellicer The use of gonadotrophin-releasing hormone analogues in women receiving oocyte donation does not affect implantation rates Hum. Reprod. 9 1994 1761 1764
31. J. Remohi, G. Ardiles, J.A. Garcia-Velasco, P. Gaitan, C. Simon, and A. Pellicer Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation Hum. Reprod. 12 1997 2271 2276
32. M.V. Sauer, and M.A. Cohen Egg and embryo donation D.K. Gardner, A. Weissman, C.M. Howles, Z. Shoham, Assisted Reproductive Techniques: Laboratory and Clinical Perspectives fourth ed. 2012 Informa Healthcare London, UK
33. R. Scott, D. Navot, H.C. Liu, and Z. Rosenwaks A human in vivo model for the luteoplacental shift Fertil. Steril. 56 1991 481 484
34. E.A. Sullivan, F. Zegers-Hochschild, R. Mansour, O. Ishihara, J. de Mouzon, K.G. Nygren, and G.D. Adamson International Committee for Monitoring Assisted Reproductive Technologies (ICMART) world report: assisted reproductive technology 2004 Hum. Reprod. 28 2013 1375 1390
35. P. Sundstrom Establishment of a successful pregnancy following in-vitro fertilization with an endometrial thickness of no more than 4 mm Hum. Reprod. 13 1998 1550 1552
36. D.E. Tourgeman, C.C. Slater, F.Z. Stanczyk, and R.J. Paulson Endocrine and clinical effects of micronized estradiol administered vaginally or orally Fertil. Steril. 75 2001 200 202
37. K.M. Trokoudes, C. Pavlides, and X. Zhang Comparison outcome of fresh and vitrified donor oocytes in an egg-sharing donation program Fertil. Steril. 95 2011 1996 2000
38. A. Trounson, J. Leeton, M. Besanko, C. Wood, and A. Conti Pregnancy established in an infertile patient after transfer of a donated embryo fertilised in vitro Br. Med. J. (Clin. Res. Ed.) 286 1983 835 838
39. Y.A. Wang, C. Farquhar, and E.A. Sullivan Donor age is a major determinant of success of oocyte donation/recipient programme Hum. Reprod. 27 2012 118 125
40. M.A. Youssef, F. van der Veen, H.G. Al-Inany, G. Griesinger, M.H. Mochtar, I. Aboulfoutouh, S.M. Khattab, and M. van Wely Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles Cochrane Database Syst. Rev. 2011 CD008046
41. U. Zenke, and R.J. Chetkowski Transfer and uterine factors are the major recipient-related determinants of success with donor eggs Fertil. Steril. 82 2004 850 856